Phase II Trial of High-Dose Rituximab with High-dose Cytarabine Mobilization Therapy and High-Dose Thiotepa, Busulfan, and Cyclophosphamide (R-TBC) Autologous Stem Cell Transplant in Patients with CNS Involvement by Non-Hodgkin Lymphoma

BACKGROUND: High-dose thiotepa, busulfan, and cyclophosphamide (TBC) with autologous stem cell transplantation (ASCT) has been used in patients with central nervous system (CNS) involvement by non-Hodgkin lymphoma (NHL). Despite limited penetration into the CNS, rituximab (R) is active in primary CN...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Chen, Yi-Bin, Batchelor, Tracy, Li, Shuli, Hochberg, Ephraim, Brezina, Mark, Jones, Sooae, Del Rio, Candice, Curtis, Morgan, Ballen, Karen K., Barnes, Jeffrey, Chi, Andrew S., Dietrich, Jorg, Driscoll, Jessica, Gertsner, Elizabeth R., Hochberg, Fred, LaCasce, Ann S., McAfee, Steven L., Spitzer, Thomas R., Nayak, Lakshmi, Armand, Philippe
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4293259/
https://ncbi.nlm.nih.gov/pubmed/25204639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29023
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados